Wealth Enhancement Advisory Services
ELTX icon

Wealth Enhancement Advisory Services’s Elicio Therapeutics ELTX Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.7K Buy
+11,972
New +$120K ﹤0.01% 3947

Other funds holding ELTX

MFA
Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Wealth Enhancement Advisory Services's ELTX Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Elicio Therapeutics (ELTX) in Q2 2026: 11,972 shares worth $41.7K. The stake represents ﹤0.01% of the portfolio and ranks #3947 among its holdings.

5 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

  • Wealth Enhancement Advisory Services held 11,972 shares of Elicio Therapeutics worth $41.7K as of Q2 2026.
  • Elicio Therapeutics was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Elicio Therapeutics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3947 holding.
  • 5 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.